| 영문 | tuberculin test | 한글 | 튜베르쿨린검사 |
|---|---|---|---|
| 설명 | 많은 서로 다른 형태의 튜베르쿨린과 다양한 투여방법에 의한 모든 종류의 결핵 피부검사법. 현재 표준 시험법으로 되어있는 가장 신빙성있는 검사로는 PPD를 피내주사하는 방법망토우 검사이다. 피내주사후 48~72시간 후에 주사부위에 직경 10mm이상으로 보이며, 만져지는 홍반과 경화가 나타나면 양성이다. 성인에게는 일반적으로 중간 강도의 튜베르쿨린(5Tu)을 사용하며, 양성반응이 나타나면 결핵균에 이전에 감염되었거나 현재 감염되어 있다는 확정적 진단이 된다. 음성반응은 결핵이 없거나, 심한 결핵감염에 의한 피부알레르기가 있을 경우, 또는 면역억제를 나타내는 병, 예를 들면 호지킨병이나 사르코이드증 등이 합병된 경우이다. |
||
| 영문 | Papanicolaou smear(test) | 한글 | 파파니콜로 도말검사 |
|---|---|---|---|
| 설명 | 줄여서 팝도말검사(Pap smear)이라고 부른다. 여성의 자궁목암의 발생을 미리 알아보기 위해 시행하는 검사법으로 미국에서는 이 방법으로 현재 자궁목암발생에 의한 사망률을 현저히 낮추고 있다. 방법은 산부인과에서 시행하며, 여성의 자궁목에서 세포를 가져다가 도말하여 현미경으로 검사한다. 요즈음에 와서는 자궁목뿐 아니라 호흡기나 비뇨기 등 분비물을 도말하여 파파니콜로 염색을 하여 검사하는 것도 여기에 포함된다. (그림 P-3). |
||
| 영문 | glucose tolerance test | 한글 | 포도당견딤검사 |
|---|---|---|---|
| 설명 | 포도당견딤 검사란 당뇨병의 진단에 사용되는 검사로 당을 체내에 투여하고 시간 별로 혈액을 채취하여 혈당의 농도를 재어서 고혈당 여부를 조사하는 검사이다. 주로 경구포도당견딤검사(oral glucose tolerance test)를 많이 하는데 이것은 10~16시간의 금식 후에 채혈을 한번 한뒤에 도당 75g을 250~300mL의 물에 녹여 5분에 걸쳐서 마시게 하고 매시간 별로 채혈을 하여 혈당의 농도를 첵크한다. 공복시에 정맥에서 채혈하여 측정한 혈당이 140mg/dL이상이거나 포도당견딤 검사 2시간후의 혈당이 200mg/dL이상일 경우에는 당뇨병으로 진단을 한다. 그러나 이 검사를 실시할 경우에 주의해야 할 점은 검사전 3일간 하루에 150g이상의 탄수화물을 섭취해야 한다는 것과 검사도중에 운동, 흡연 등을 하지 않아야 한다는 것이다. |
||
| 영문 | blood test | 한글 | 혈액검사 |
|---|---|---|---|
| 설명 | 혈액형이나 질병 유무 따위를 알기 위하여 피를 뽑아 행하는 검사. 몸 전체의 장기나 조직에 병터가 있으면 이들 성분에 변화가 있게 되어 진단에 큰 도움을 준다. |
||
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
|---|---|
| LFT | latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio... |
| LTT | lactose tolerance test; leucine tolerance test; limited treadmill test; lymphocyte transformation te... |
| SAT | saliva alcohol test; satellite; serum antitrypsin; single-agent chemotherapy; slide agglutination te... |
| SRT | sedimentation rate test; simple reaction time; sinus node recovery time; sitting root test; speech r... |
| antigen-antibody reaction | The phenomenon, occurring in vitro or in vivo, of antibody combining with antigen of the type that stimulated the formation of the antibody, thereby resulting in agglutination, precipitation, complement fixation, greater susceptibility to ingestion and destruction by phagocytes, or neutralization of exotoxin. See: skin test. (05 Mar 2000) |
|---|---|
| anti-idiotype antibody | <immunology> An antibody directed against the antigen specific part of the sequence of an antibody or T-cell receptor and thus recognise the binding sites of other antibodies. In principle an anti-idiotype antibody should inhibit a specific immune response and they are important to the regulation of the immune system. (13 Nov 1997) |
| anti-insulin antibody | A serologic blood test that is used to detect antibodies to insulin. This test is performed in insulin dependent diabetics who exhibit insulin resistance. The presence of antibodies denotes a positive result. (27 Sep 1997) |
| antinuclear antibody | <immunology> Antinuclear antibody is an antibody that react against components of the cell nucleus such as DNA, RNA, histone or non-histone proteins. These antibodies are present in a variety of immunologic or autoimmune diseases including systemic lupus erythematosus, systemic sclerosis, scleroderma, Sjogren's syndrome, rheumatoid arthritis, polymyositis, dermatomyositis and in persons taking hydralazine, procainamide or isoniazid. A serologic measurement for antinuclear antibodies can aid in the diagnosis of unexplained arthritis, rashes or chest pains. Acronym: ANA (12 Jan 1998) |
| anti-P antibody | <haematology, investigation> A serologic blood test used to detect the Donath-landsteiner antibody in serum. This test is performed in cases of suspected paroxysmal cold haemoglobinuria. A normal result is indicated by an absence of antibodies. The antibody is directed toward the P-antigen complex which is located on the surface of red blood cells. In some way, cold temperatures trigger the antibody to bind to this site. (13 Jan 1998) |
| antiparietal cell antibody | <immunology> A serologic blood test which measures the presence of antibodies to gastric parietal cells. Less than 2% of the general population will be antibody positive although this can be higher in the elderly. Approximately 90% of individuals with pernicious anaemia will be antibody positive. A positive result may also be seen in atrophic gastritis, gastric ulcer, thyroid disease, iron deficiency anaemia and diabetes. (13 Jan 1998) |
| antiphospholipid antibody | <immunology, syndrome> An uncommon disorder that is characterised by hypercoagulability due to the presence of antibodies against phospholipids. These patients exhibit a tendency for recurrent and life-threatening thrombosis and embolic events (for example stroke). Individuals with antiphospholipid syndrome also have an increased tendency toward deep venous thrombosis, myocardial infarction and spontaneous abortions in females. Antiphospholipid syndrome may be seen by itself or in association with other autoimmune illnesses (for example lupus) or with some infections. Treatment includes long-term heparin and warfarin. (13 Jan 1998) |
| antiphospholipid antibody syndrome | <syndrome> An immune disorder characterised by the presence of abnormal antibodies in the blood associated with certain medical conditions including abnormal blood clotting, migraine headaches, premature miscarriage, and low blood platelet counts (thrombocytopenia). (12 Dec 1998) |
| antithyroglobulin antibody | <endocrinology, immunology> A serologic blood test which measures the antithyroglobulin antibodies in the blood. Thyroglobulin is a protein found in thyroid tissue. It is the source of thyroid hormones in the body. The presence of antibodies to this protein can result in decreased thyroid gland function. A negative assay is considered normal. Conditions where the assay may be positive include: lupus, rheumatoid arthritis, Hashimoto's thyroiditis, thyrotoxicosis, hypothyroidism, thyroid cancer, myxoedema, Sjogren's syndrome and autoimmune haemolytic anaemia. (13 Jan 1998) |
| avidity antibody | The sum total of the functional binding strength between a polyvariant and its antibody. The total binding strength represents the sum strength of all the affinity bonds. (05 Mar 2000) |
| binding sites, antibody | Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of the fab fragment of the immunoglobulin. (12 Dec 1998) |
| bivalent antibody | Antibody that causes a visible reaction with specific antigen as in agglutination, precipitation, and so on; so-called because according to the "lattice theory" aggregation occurs when the antibody molecule has two or more binding sites that can crosslink one antigen particle to another; probably a characteristic of the class of immunoglobulin. (05 Mar 2000) |
| blocking antibody | An antibody used in a reaction to prevent some other reaction taking place, for example one antibody competing with another for a cell surface receptor. See: desensitisation. (18 Nov 1997) |
| reaginic antibody | <immunology> A type of antibody which is able to attach itself to the surfaces of cells without needing specific combining sites. A homocytotropic antibody will only bind to cells which are from the same species as itself. (09 Oct 1997) |
| maternal antibody | Any antibody transferred from a mammalian mother transplacentally into the foetus. See under immunoglobulin for details of the classes of Ig that are transferred to the foetus. (18 Nov 1997) |